H.R. 7535 · 118th Congress · House

Prescription Drug Supply Chain Pricing Transparency Act

Active· Referred to the Subcommittee on Health.
Introduced
Mar 5, 24
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending

Action Timeline

6
  1. DEC 17, 2024Committee

    Referred to the Subcommittee on Health.

  2. MAR 08, 2024Committee

    Referred to the Subcommittee on Health.

  3. MAR 05, 2024IntroReferral

    Introduced in House

  4. MAR 05, 2024IntroReferral

    Introduced in House

  5. MAR 05, 2024IntroReferral

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  6. MAR 05, 2024IntroReferral

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Committees

4

Health Subcommittee

hswm02

Referred: Dec 17, 2024

Active

Health Subcommittee

hsif14

Referred: Mar 8, 2024

Active

Ways and Means Committee

hswm00

Referred: Mar 5, 2024

Active

Energy and Commerce Committee

hsif00

Referred: Mar 5, 2024

Active